• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性大甲状腺髓样癌:淋巴结受累的预测因素

Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

作者信息

Aubert Sébastien, Berdelou Amandine, Gnemmi Viviane, Behal Hélène, Caiazzo Robert, D'herbomez Michèle, Pigny Pascal, Wemeau Jean Louis, Carnaille Bruno, Renaud Florence, Bouchindhomme Brigitte, Leteurtre Emmanuelle, Perrais Michael, Pattou François, Do Cao Christine

机构信息

Institut de Pathologie, Centre de Biologie Pathologie, CHRU de Lille, 59037, Lille, France.

Faculté de Médecine, Université de Lille, 59045, Lille, France.

出版信息

Virchows Arch. 2018 Mar;472(3):461-468. doi: 10.1007/s00428-018-2303-7. Epub 2018 Feb 1.

DOI:10.1007/s00428-018-2303-7
PMID:29388012
Abstract

Lymph node involvement (LNI) is one of the most important prognostic factors for poor survival in medullary thyroid carcinoma (MTC). At diagnosis, LNI is found in over 50% of sporadic MTCs, and especially in large tumours. Cervical lymph node dissection is therefore mandatory during MTC surgery. However, some large tumours (responsible for high preoperative basal calcitonin levels) are found to lack LNI, and can be cured definitely. Preoperative detection of these particular tumours might spare patients from undergoing extensive cervical dissection. The objective of the present retrospective study of a series of large sporadic MTCs was to identify clinical, biological and pathological factors that were predictive of LNI. Consecutive cases of large, sporadic MTCs (measuring at least 1 cm in diameter) were retrieved and reviewed. The levels of several mature microRNAs (miRs) in paraffin-embedded samples were assessed using qPCR. Of the 54 MTCs, 26 had LNI and 28 were pN0. Relative to pN0 patients, patients with LNI had a significant higher preoperative basal calcitonin level (p = 0.0074) and a greater prevalence of infiltrative margins (p < 0.0001), lymphovascular invasion (p = 0.0004), extrathyroidal extension (p < 0.0001), a higher pT stage (p = 0.0003) and more abundant desmoplastic stroma (p = 0.0006). Tumour expression levels of miR-21 (p = 0.0008) and miR-183 (p = 0.0096) were higher in the LNI group. The abundance of desmoplastic stroma (p = 0.007) and the miR-21 expression level (p = 0.0026) were independent prognostic factors for LNI. The abundance of desmoplastic stroma and high levels of miR-21 expression were strong indicators of LNI, and may thus help the surgeon to choose the extent of cervical lymph node dissection for large, sporadic MTCs with no preoperatively obvious LNI.

摘要

淋巴结受累(LNI)是甲状腺髓样癌(MTC)患者生存预后不良的最重要因素之一。在确诊时,超过50%的散发性MTC患者存在LNI,尤其是在肿瘤较大的患者中。因此,MTC手术期间必须进行颈部淋巴结清扫。然而,一些导致术前基础降钙素水平升高的大肿瘤却未发现LNI,且可被彻底治愈。术前检测这些特殊肿瘤可能使患者免于接受广泛的颈部清扫。本项针对一系列大型散发性MTC的回顾性研究的目的是确定预测LNI的临床、生物学和病理学因素。收集并回顾了连续的大型散发性MTC病例(直径至少1厘米)。使用qPCR评估石蜡包埋样本中几种成熟微小RNA(miR)的水平。在54例MTC中,26例存在LNI,28例为pN0。与pN0患者相比,LNI患者术前基础降钙素水平显著更高(p = 0.0074),浸润性边缘的发生率更高(p < 0.0001),存在淋巴管侵犯(p = 0.0004)、甲状腺外侵犯(p < 0.0001),pT分期更高(p = 0.0003),促纤维增生性间质更丰富(p = 0.0006)。LNI组中miR-21(p = 0.0008)和miR-183(p = 0.0096)的肿瘤表达水平更高。促纤维增生性间质的丰富程度(p = 0.007)和miR-21表达水平(p = 0.0026)是LNI的独立预后因素。促纤维增生性间质的丰富程度和高水平的miR-21表达是LNI的有力指标,因此可能有助于外科医生为术前无明显LNI的大型散发性MTC选择颈部淋巴结清扫的范围。

相似文献

1
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.散发性大甲状腺髓样癌:淋巴结受累的预测因素
Virchows Arch. 2018 Mar;472(3):461-468. doi: 10.1007/s00428-018-2303-7. Epub 2018 Feb 1.
2
Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.散发性和遗传性甲状腺髓样癌中央区及双侧淋巴结清扫的理论依据
J Clin Endocrinol Metab. 2003 May;88(5):2070-5. doi: 10.1210/jc.2002-021713.
3
Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.散发性髓样甲状腺癌中颈侧区淋巴结转移的术前临床及超声预测因素。
Thyroid. 2018 Mar;28(3):362-368. doi: 10.1089/thy.2017.0514. Epub 2018 Feb 15.
4
Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.散发性与家族性甲状腺髓样微小癌:对50例连续患者的组织病理学研究
Am J Surg Pathol. 2001 Oct;25(10):1245-51. doi: 10.1097/00000478-200110000-00004.
5
Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.甲状腺髓样癌中生长抑素受体2A的表达与淋巴结转移相关。
APMIS. 2016 Oct;124(10):839-45. doi: 10.1111/apm.12584. Epub 2016 Aug 19.
6
Biological relevance of medullary thyroid microcarcinoma.甲状腺髓样微癌的生物学相关性。
J Clin Endocrinol Metab. 2012 May;97(5):1547-53. doi: 10.1210/jc.2011-2534. Epub 2012 Mar 7.
7
Nodal metastasis microRNA expression correlates with the primary tumour in MTC.在甲状腺髓样癌中,淋巴结转移的微小RNA表达与原发肿瘤相关。
ANZ J Surg. 2014 Apr;84(4):235-9. doi: 10.1111/j.1445-2197.2012.06291.x. Epub 2012 Oct 16.
8
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.挪威2A型多发性内分泌腺瘤病的全国性研究:甲状腺髓样癌临床病程的预测和预后因素
Thyroid. 2016 Sep;26(9):1225-38. doi: 10.1089/thy.2015.0673. Epub 2016 Aug 11.
9
Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.放弃针对无包膜单发散发性甲状腺髓样癌中去分化型的淋巴结清扫。
Surgery. 2022 Feb;171(2):360-367. doi: 10.1016/j.surg.2021.07.035. Epub 2021 Oct 1.
10
Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌患者颈部淋巴结转移的危险因素分析
J Int Med Res. 2018 May;46(5):1982-1989. doi: 10.1177/0300060518762684. Epub 2018 Mar 23.

引用本文的文献

1
[Update on medullary thyroid carcinoma-What is relevant for surgeons?].[甲状腺髓样癌的最新进展——对外科医生有何重要意义?]
Chirurgie (Heidelb). 2025 May 19. doi: 10.1007/s00104-025-02289-w.
2
Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept.基于治疗前基础降钙素和术中诊断促纤维增生性基质反应的甲状腺髓样癌(MTC)个体化手术:一种新手术概念的提议
Ann Surg Oncol. 2025 Mar 6. doi: 10.1245/s10434-025-16958-x.
3
ASO Author Reflections: Combining Two Easily Available Parameters Can Help to Individualize Lymph Node Surgery in Medullary Thyroid Cancer (MTC) Without Compromising Cure Rates.

本文引用的文献

1
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
2
The PDCD4/miR-21 pathway in medullary thyroid carcinoma.甲状腺髓样癌中的PDCD4/miR-21信号通路
Hum Pathol. 2015 Jan;46(1):50-7. doi: 10.1016/j.humpath.2014.09.006. Epub 2014 Oct 2.
3
Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.差异性miRNA表达决定了滤泡状甲状腺癌的迁移能力及凋亡减少。
ASO作者反思:结合两个易于获得的参数有助于在不影响治愈率的情况下对甲状腺髓样癌(MTC)的淋巴结手术进行个体化。
Ann Surg Oncol. 2025 Feb 28. doi: 10.1245/s10434-025-17088-0.
4
Could microRNA Analysis Help in the Management of Medullary Thyroid Cancer?微小RNA分析能否有助于甲状腺髓样癌的管理?
Cancers (Basel). 2025 Feb 13;17(4):629. doi: 10.3390/cancers17040629.
5
Translating the desmoplastic microenvironment of medullary thyroid cancer into surgical practice.将甲状腺髓样癌的促纤维增生性微环境转化为外科实践。
Endocrine. 2025 Feb;87(2):430-435. doi: 10.1007/s12020-024-04060-3. Epub 2024 Sep 30.
6
Latest Progress in Risk-Adapted Surgery for Medullary Thyroid Cancer.甲状腺髓样癌风险适应性手术的最新进展
Cancers (Basel). 2024 Feb 24;16(5):917. doi: 10.3390/cancers16050917.
7
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.C 细胞神经内分泌肿瘤更新:甲状腺髓样癌的预后和预测的组织病理学和分子特征。
Endocr Pathol. 2023 Mar;34(1):1-22. doi: 10.1007/s12022-023-09753-5. Epub 2023 Mar 8.
8
Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.正常及癌相关成纤维细胞以及胰腺导管腺癌的BxPc3和MIA PaCa-2细胞系中所选微小RNA的表达
Int J Mol Sci. 2023 Feb 10;24(4):3617. doi: 10.3390/ijms24043617.
9
Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma.淋巴结清扫对甲状腺癌患者全甲状腺切除术后并发症的影响
Cancers (Basel). 2022 Nov 7;14(21):5462. doi: 10.3390/cancers14215462.
10
Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.单侧甲状腺髓样癌切除术:寻求临床实践指南。
Front Endocrinol (Lausanne). 2022 Jul 11;13:875875. doi: 10.3389/fendo.2022.875875. eCollection 2022.
Mol Cell Endocrinol. 2014 May 5;388(1-2):1-9. doi: 10.1016/j.mce.2014.02.011. Epub 2014 Mar 12.
4
Deregulation of microRNA expression in thyroid neoplasias.甲状腺肿瘤中 microRNA 表达的失调。
Nat Rev Endocrinol. 2014 Feb;10(2):88-101. doi: 10.1038/nrendo.2013.223. Epub 2013 Nov 19.
5
The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.miR-21/PDCD4/AP-1 自调节反馈环作为肝纤维化发展的驱动力。
J Biol Chem. 2013 Dec 27;288(52):37082-93. doi: 10.1074/jbc.M113.517953. Epub 2013 Nov 6.
6
Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.循环 miR-21 对癌症的诊断和预后价值:系统评价和荟萃分析。
Gene. 2014 Jan 1;533(1):389-97. doi: 10.1016/j.gene.2013.09.038. Epub 2013 Sep 26.
7
Extent of surgery in clinically evident but operable MTC - when is central and/or lateral lympadenectomy indicated?临床诊断明确但可手术切除的甲状腺髓样癌的手术范围——何时需要进行中央区和/或侧方淋巴结清扫?
Thyroid Res. 2013 Mar 14;6 Suppl 1(Suppl 1):S3. doi: 10.1186/1756-6614-6-S1-S3.
8
Increased circulating miR-21 levels are associated with kidney fibrosis.循环 miR-21 水平的升高与肾脏纤维化有关。
PLoS One. 2013;8(2):e58014. doi: 10.1371/journal.pone.0058014. Epub 2013 Feb 28.
9
Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.甲状腺乳头状癌中 miRNAs 的表达及其与 BRAFV600E 突变的关系。
Eur J Endocrinol. 2013 Apr 15;168(5):675-81. doi: 10.1530/EJE-12-1029. Print 2013 May.
10
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.家族性和散发性髓样甲状腺癌中的 microRNA 谱:与 RET 状态和预后的初步关系。
Thyroid. 2012 Sep;22(9):890-6. doi: 10.1089/thy.2012.0045. Epub 2012 Jun 29.